The influence of gravidity on Down's syndrome screening with free beta hCG
- 1 January 1995
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 15 (1) , 87-89
- https://doi.org/10.1002/pd.1970150119
Abstract
Total human chorionic gonadotropin (hCG) levels have been shown in one previous small study to vary with gravidity. In order to establish if maternal serum free beta hCG was similarly affected, approximately 4500 pregnancies of varying gravidity were analysed. The results indicated that there was a 6 per cent higher median MOM in primigravid compared with multigravid women. The impact of such elevation in Down's syndrome screening programmes will be minimal.Keywords
This publication has 17 references indexed in Scilit:
- Down's syndrome screening in multiple pregnancies using alpha‐fetoprotein and free beta hCGPrenatal Diagnosis, 1994
- Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndromePrenatal Diagnosis, 1994
- Human chorionic gonadotropin and unconjugated oestriol measurements in insulin‐dependent diabetic pregnant women being screened for fetal down syndromePrenatal Diagnosis, 1994
- Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.BMJ, 1993
- Antenatal screening for Down's syndrome.BMJ, 1993
- Screening For Down's Syndrome. The Role Of Intact Hcg and Free Subunit MeasurementScandinavian Journal of Clinical and Laboratory Investigation, 1993
- Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin‐dependent diabetes: implications for screening for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Screening for Down's syndrome using serum alpha fetoprotein: a retrospective study indicating caution.BMJ, 1985